监管与产业动态· MHRA (UK)·· 16 hours agoPickScore81
MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndrome
In brief
The UK MHRA authorised plozasiran (Redemplo) on 19 October 2026 for adults with familial chylomicronaemia syndrome. Original link: https://gov.uk/government/news/mhra-authorises-plozasiran-redemplo-for-adults-with-familial-chylomicronaemia-syndrome
Why it matters
The MHRA authorisation notice gives the date, drug name and full indication, useful for verifying plozasiran's UK regulatory status.
Source: 监管与产业动态 · gov.uk